LIGAND PHARMACEUTICALS INCORPORATED Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$33.36 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-02-28
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$17.48M.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was $404.00K, a 97.06% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$895.00K, a 102.91% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$15.38M, a 184.97% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$33.36M, a 158.39% decline from fiscal 2021.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was $57.14M.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$2.98M, a 100.47% decline from fiscal 2019.
- LIGAND PHARMACEUTICALS INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was $629.30M, a 339.09% increase from fiscal 2018.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$17.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$17.08M derived: sum of 2 quarters · filed 2023-02-28 | -$17.98M derived: sum of 3 quarters · filed 2023-02-28 | -$33.36M 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$491.00K derived: sum of 2 quarters · filed 2022-11-08 | -$15.88M 10-Q · filed 2022-11-08 | -$21.29M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2022-06-30 | -$895.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$16.28M 10-Q · filed 2022-08-09 | -$21.70M derived: sum of 3 quarters · filed 2023-02-28 | -$7.97M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2022-03-31 | -$15.38M 10-Q · filed 2022-05-09 | -$20.80M derived: sum of 2 quarters · filed 2023-02-28 | -$7.08M derived: sum of 3 quarters · filed 2023-02-28 | $23.65M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-12-31 | -$5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $8.31M derived: sum of 2 quarters · filed 2023-02-28 | $39.03M derived: sum of 3 quarters · filed 2023-02-28 | $57.14M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $13.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $44.45M derived: sum of 2 quarters · filed 2022-11-08 | $62.55M 10-Q · filed 2022-11-08 | $68.31M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $30.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $48.83M 10-Q · filed 2022-08-09 | $54.59M derived: sum of 3 quarters · filed 2023-02-28 | $47.89M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $18.11M 10-Q · filed 2022-05-09 | $23.87M derived: sum of 2 quarters · filed 2023-02-28 | $17.17M derived: sum of 3 quarters · filed 2023-02-28 | $39.25M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$940.00K derived: sum of 2 quarters · filed 2023-02-28 | $21.15M derived: sum of 3 quarters · filed 2023-02-28 | -$2.98M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $15.38M derived: sum of 2 quarters · filed 2021-11-09 | -$8.75M 10-Q · filed 2021-11-09 | -$16.11M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $22.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$2.04M 10-Q · filed 2021-08-03 | -$9.41M derived: sum of 3 quarters · filed 2022-02-28 | -$24.66M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$24.13M 10-Q · filed 2021-05-06 | -$31.50M derived: sum of 2 quarters · filed 2022-02-28 | -$46.75M derived: sum of 3 quarters · filed 2022-02-28 | -$61.17M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$22.62M derived: sum of 2 quarters · filed 2022-02-28 | -$37.03M derived: sum of 3 quarters · filed 2022-02-28 | $629.30M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | -$15.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$29.67M derived: sum of 2 quarters · filed 2020-11-06 | $636.67M 10-Q · filed 2020-11-06 | $594.18M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | -$14.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $651.92M 10-Q · filed 2020-08-07 | $609.44M derived: sum of 3 quarters · filed 2021-02-24 | $676.80M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $666.34M 10-Q · filed 2020-05-08 | $623.86M derived: sum of 2 quarters · filed 2021-02-24 | $691.22M derived: sum of 3 quarters · filed 2021-02-24 | $764.38M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$42.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $24.88M derived: sum of 2 quarters · filed 2021-02-24 | $98.04M derived: sum of 3 quarters · filed 2021-02-24 | $143.32M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $67.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $140.52M derived: sum of 2 quarters · filed 2019-11-08 | $185.80M 10-Q · filed 2019-11-08 | $178.79M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $73.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $118.44M 10-Q · filed 2019-08-08 | $111.43M derived: sum of 3 quarters · filed 2020-02-27 | $119.86M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $45.28M 10-Q · filed 2019-05-09 | $38.27M derived: sum of 2 quarters · filed 2020-02-27 | $46.70M derived: sum of 3 quarters · filed 2020-02-27 | $52.76M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.42M derived: sum of 2 quarters · filed 2020-02-27 | $7.48M derived: sum of 3 quarters · filed 2020-02-27 | $12.56M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $14.49M derived: sum of 2 quarters · filed 2018-11-08 | $19.57M 10-Q · filed 2018-11-08 | $16.44M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $11.14M 10-Q · filed 2018-08-08 | $8.01M derived: sum of 3 quarters · filed 2019-02-28 | $9.06M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $5.08M 10-Q · filed 2018-05-09 | $1.95M derived: sum of 2 quarters · filed 2019-02-28 | $3.00M derived: sum of 3 quarters · filed 2019-02-28 | -$3.17M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$2.08M derived: sum of 2 quarters · filed 2019-02-28 | -$8.24M derived: sum of 3 quarters · filed 2019-02-28 | -$1.64M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $1.05M 10-Q · filed 2016-11-14 | -$5.12M derived: sum of 2 quarters · filed 2016-11-14 | $1.49M 10-Q · filed 2017-11-09 | $7.83M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | -$6.17M 10-Q · filed 2016-11-14 | -$5.76M 10-Q · filed 2016-08-04 | $438.00K 10-Q · filed 2017-08-09 | $845.00K 10-Q · filed 2016-08-04 | $6.78M derived: sum of 3 quarters · filed 2018-03-01 | $205.94M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $6.61M 10-Q · filed 2017-05-09 | $12.95M derived: sum of 2 quarters · filed 2018-03-01 | $212.11M derived: sum of 3 quarters · filed 2018-03-01 | $234.14M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $205.51M derived: sum of 2 quarters · filed 2018-03-01 | $227.53M derived: sum of 3 quarters · filed 2018-03-01 | $227.44M 10-K · filed 2018-03-01 | $254.93M 10-K · filed 2016-02-26 | |||
| 2015-09-30 | $199.16M 10-Q · filed 2016-11-14 | $224.54M 10-Q · filed 2015-11-09 | $221.19M derived: sum of 2 quarters · filed 2016-11-14 | $221.10M 10-Q · filed 2016-11-14 | $246.48M 10-Q · filed 2015-11-09 | $227.84M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $22.03M 10-Q · filed 2016-11-14 | $21.94M 10-Q · filed 2016-11-14 | $28.67M derived: sum of 3 quarters · filed 2017-02-28 | $29.45M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$89.00K 10-Q · filed 2016-11-14 | $6.64M derived: sum of 2 quarters · filed 2017-02-28 | $7.42M derived: sum of 3 quarters · filed 2017-02-28 | $8.71M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $7.51M derived: sum of 2 quarters · filed 2017-02-28 | $8.80M derived: sum of 3 quarters · filed 2017-02-28 | $10.89M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $777.00K 10-Q · filed 2015-11-09 | $2.06M derived: sum of 2 quarters · filed 2015-11-09 | $4.16M 10-Q · filed 2015-11-09 | $6.03M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2014-06-30 | $1.29M 10-Q · filed 2015-08-05 | $3.38M 10-Q · filed 2015-08-05 | $5.25M derived: sum of 3 quarters · filed 2016-11-14 | $7.22M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2014-03-31 | $2.10M 10-Q · filed 2015-05-11 | $3.97M derived: sum of 2 quarters · filed 2016-11-14 | $5.93M derived: sum of 3 quarters · filed 2016-11-14 | $12.02M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2013-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | $3.83M derived: sum of 2 quarters · filed 2016-11-14 | $9.93M derived: sum of 3 quarters · filed 2016-11-14 | $11.42M 10-K · filed 2016-11-14 | ||||
| 2013-09-30 | $1.97M 10-Q · filed 2014-10-31 | $8.06M derived: sum of 2 quarters · filed 2014-10-31 | $9.55M 10-Q · filed 2014-10-31 | |||||
| 2013-06-30 | $6.09M 10-Q · filed 2014-08-05 | $7.59M 10-Q · filed 2014-08-05 | ||||||
| 2012-12-31 | -$527.00K 10-K · filed 2015-02-23 |